The pharmaceutical industry is rapidly evolving, with growing demand for high-performance Active Pharmaceutical Ingredients (APIs). Dulaglutide, a GLP-1 receptor agonist, represents example of this trend. To meet this https://tirzepatides.us/heterocyclic-compounds